Phase 1 Ischemic Stroke Clinical Trials
11 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–11 of 11 trials
Recruiting
Phase 1Phase 2
A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke
Chronic Ischemic Stroke
Astellas Pharma Inc84 enrolled1 locationNCT07318714
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants
Ischemic Stroke
Longwood Pharmaceuticals (Hangzhou) Co., Ltd.76 enrolled1 locationNCT07371455
Recruiting
Phase 1Phase 2
A Study of the Safety, Tolerability and Preliminary Efficacy of B2065 in Patients With Acute Ischemic Stroke.
Acute Ischemic Stroke
Tasly Pharmaceutical Group Co., Ltd54 enrolled1 locationNCT07371624
Recruiting
Phase 1
The Safety and Efficacy of NouvSoma001 in Ischemic Stroke
Ischemic Stroke
Wei Wang69 enrolled1 locationNCT06612710
Recruiting
Phase 1Phase 2
The Effect of GD-iExo-003 in Acute Ischemic Stroke
Acute Ischemic Stroke
Xuanwu Hospital, Beijing29 enrolled1 locationNCT06138210
Recruiting
Phase 1Phase 2
Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke
Acute Ischemic Stroke
Dongzhimen Hospital, Beijing72 enrolled1 locationNCT06857487
Recruiting
Phase 1Phase 2
Verapamil for Neuroprotection in Stroke
Ischemic Stroke
Global Neurosciences Institute60 enrolled3 locationsNCT03347786
Recruiting
Phase 1
Study on Hibernation-like Therapy Based on Mechanical Thrombectomy
Acute Ischemic Stroke
Capital Medical University32 enrolled1 locationNCT06663631
Recruiting
Phase 1
Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414
Ischemic Stroke
Chendu DIAO Nine Hong Pharmaceutical Factory82 enrolled1 locationNCT06525168
Completed
Phase 1
A Phase 1 study to evaluate Safety, Tolerability and Pharmacokinetics of LMR-123 in Healthy Subjects
Acute Ischemic Stroke
Australia Medical Industries Pty Ltd.52 enrolled1 locationACTRN12619001609145
Completed
Phase 1
A Dose-Escalation Safety Study of Yindan Softgels in Healthy Subjects
ischemic stroke sequelaeunstable angina pectoris of coronary heart disease (CHD)
Axeon Research (Au) Pty Ltd.40 enrolled1 locationACTRN12618000582257